ACADIA PHARMACEUTICALS INC 4
4 · ACADIA PHARMACEUTICALS INC · Filed Sep 4, 2014
Insider Transaction Report
Form 4
Wells William McDowall
Director
Transactions
- Sale
Common Stock
2014-09-02$26.76/sh−15,000$401,400→ 15,000 total - Exercise/Conversion
Stock Option (right to buy)
2014-09-02−10,000→ 0 totalExercise: $1.36Exp: 2022-06-07→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock option (right to buy)
2014-09-02−20,000→ 24,117 totalExercise: $1.36Exp: 2022-06-07→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2014-09-02$1.36/sh+30,000$40,800→ 30,000 total - Sale
Common Stock
2014-09-02$27.00/sh−15,000$405,000→ 0 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2014.
- [F2]25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following June 8, 2012.